New Recruiting Trial: Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement
WHY IT MATTERS
This trial is now recruiting patients undergoing TIPS placement — if you have advanced liver disease with portal hypertension and are scheduled for this procedure, you may be eligible to contribute to research that could improve how doctors manage bleeding risks in liver disease patients.
Researchers are looking for patients who need a procedure called a transjugular intrahepatic portosystemic shunt (TIPS) to help study how blood clotting works in patients with liver disease. This trial will examine blood clotting patterns before and after the procedure to better understand how TIPS affects the body's ability to form and break down blood clots. The study is recruiting patients starting in April 2026 and is being run by hospitals in Paris.
NCT ID: NCT07439939 Title: Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement Status: RECRUITING Sponsor: Assistance Publique - Hôpitaux de Paris Start date: 2026-04-02 URL: https://clinicaltrials.gov/study/NCT07439939 Source: UniteRare clinical trials database
ASK YOUR DOCTOR
If you have liver disease and your doctor has mentioned TIPS as a treatment option, ask them whether you might be eligible for this trial or if they know of similar studies recruiting in your area.